Investeringsoversigt
514 Investeringer
| Titel | Periode Sortér faldende | Program | |
|---|---|---|---|
| Interactive Sound Zones for Better Living ISOBEL | 2019 - 2023 | Grand Solutions
|
|
|
Interactive Sound Zones for Better Living ISOBEL
Periode
2019 - 2023
Region
Region Nordjylland Program
Grand Solutions Fagområde
Produktion, Materialer, Digitalisering og IKT Investering
Percentage
63.61 Fondens investering
17,9 mio. Samlet budget
28,1 mio. Projektdeltagere
Aalborg University, Aalborg University, Bang &: Olufsen A/S, SoundFocus A/S, Wavecare ApS Projektleder
Aalborg Universitet
Læs mere om projektet
| |||
| VR8 – Virtual Reality Aid for Anxiety Disorders VR8 | 2019 - 2024 | Grand Solutions
|
|
|
VR8 – Virtual Reality Aid for Anxiety Disorders VR8
Periode
2019 - 2024
Region
Region Syddanmark Program
Grand Solutions Fagområde
Produktion, Materialer, Digitalisering og IKT Investering
Percentage
71.26 Fondens investering
12,4 mio. Samlet budget
17,4 mio. Projektdeltagere
Centre for Telepsychiatry, University of Southern Denmark, University of Southern Denmark, University of Southern Denmark, Odense University Hospital, iMotions A/S Projektleder
Region Syddanmark
Læs mere om projektet
| |||
| Programming Ignition for Robotic Assembly Tasks - PIRAT | 2019 - 2023 | Grand Solutions
|
|
|
Programming Ignition for Robotic Assembly Tasks - PIRAT
Periode
2019 - 2023
Region
Region Syddanmark Program
Grand Solutions Fagområde
Produktion, Materialer, Digitalisering og IKT Investering
Percentage
67.31 Fondens investering
10,5 mio. Samlet budget
15,6 mio. Projektdeltagere
University of Southern Denmark, Universal Robots A/S, Teknologisk Institut, Terma A/S Projektleder
Syddansk Universitet (University of Southern Denmark)
Læs mere om projektet
| |||
| Fighting auditory hallucinations by simulation training in a Virtual Reality environment CHALLENGE | 2019 - 2023 | Grand Solutions
|
|
|
Fighting auditory hallucinations by simulation training in a Virtual Reality environment CHALLENGE
Periode
2019 - 2023
Region
Region Hovedstaden Program
Grand Solutions Fagområde
Biotek, Medico og Sundhed Investering
Percentage
74.02 Fondens investering
13,3 mio. Samlet budget
18,0 mio. Projektdeltagere
Mental Health Services in the Capital Region of Denmark (Region Hovedstadens Psykiatri), Aalborg Universitetshospital, Khora ApS, Region Syddanmark, Lokalpsykiatri Esbjerg Projektleder
Region Hovedstaden
Læs mere om projektet
| |||
| AVLX-144 as a novel treatment for ischemic stroke 144STROKE | 2019 - 2021 | Grand Solutions
|
|
|
AVLX-144 as a novel treatment for ischemic stroke 144STROKE
Periode
2019 - 2021
Region
Region Hovedstaden Program
Grand Solutions Fagområde
Biotek, Medico og Sundhed Investering
Percentage
75.07 Fondens investering
19,9 mio. Samlet budget
26,5 mio. Projektdeltagere
University of Copenhagen, Avilex Pharma, Copenhagen University Hospital (Rigshospitalet), University of Southern Denmark, Clinical Research Services Turku, Turku PET Center Projektleder
AVILEX PHARMA ApS
Læs mere om projektet
| |||
| CAncer REcognition with circular DNA fingerprinting CARE DNA | 2019 - 2021 | Grand Solutions
|
|
|
CAncer REcognition with circular DNA fingerprinting CARE DNA
Periode
2019 - 2021
Region
Region Hovedstaden Program
Grand Solutions Fagområde
Biotek, Medico og Sundhed Investering
Percentage
72.92 Fondens investering
13,2 mio. Samlet budget
18,1 mio. Projektdeltagere
University of Copenhagen, Herlev Hospital, Chemometec A/S, Roche Sequencing Solutions Inc. Projektleder
Københavns Universitet
Læs mere om projektet
| |||
| INTRODUCING MEASLES-MUMPS-RUBELLA VACCINATION AT 6 MONTHS OF AGE: AN OPPORTUNITY T0 IMPROVE VACCINE COVERAGE, INCREASE CHILD HEALTH AND REDUCE THE COST OF INFECTIOUS CHILDHOOD DISEASES IN A HIGH-INCOME SETTING VACOP. Vaccine Advancement in | 2019 - 2023 | Grand Solutions
|
|
|
INTRODUCING MEASLES-MUMPS-RUBELLA VACCINATION AT 6 MONTHS OF AGE: AN OPPORTUNITY T0 IMPROVE VACCINE COVERAGE, INCREASE CHILD HEALTH AND REDUCE THE COST OF INFECTIOUS CHILDHOOD DISEASES IN A HIGH-INCOME SETTING VACOP. Vaccine Advancement in
Periode
2019 - 2023
Region
Region Hovedstaden Program
Grand Solutions Fagområde
Biotek, Medico og Sundhed Investering
Percentage
76.92 Fondens investering
22,7 mio. Samlet budget
29,5 mio. Projektdeltagere
Copenhagen University Hospital (Rigshospitalet), Herlev Hospital, University of Copenhagen Projektleder
Region Hovedstaden
Læs mere om projektet
| |||
| Human Milk Oligosaccharides EXpanded PORTfolio by novel enzymatic routes HMO-EXPORT | 2019 - 2022 | Grand Solutions
|
|
|
Human Milk Oligosaccharides EXpanded PORTfolio by novel enzymatic routes HMO-EXPORT
Periode
2019 - 2022
Region
Region Hovedstaden Program
Grand Solutions Fagområde
Biotek, Medico og Sundhed Investering
Percentage
63.12 Fondens investering
7,1 mio. Samlet budget
11,3 mio. Projektdeltagere
Glycom A/S, Technical University of Denmark Projektleder
GLYCOM A/S
Læs mere om projektet
| |||
| Mechanism Of Regenerative Cell Action (MORCA) MORCA MORCA | 2019 - 2024 | Grand Solutions
|
|
|
Mechanism Of Regenerative Cell Action (MORCA) MORCA MORCA
Periode
2019 - 2024
Region
Region Syddanmark Program
Grand Solutions Fagområde
Biotek, Medico og Sundhed Investering
Percentage
70.64 Fondens investering
5,0 mio. Samlet budget
7,1 mio. Projektdeltagere
Odense University Hospital, Charité - Universiitätsmedizin Berlin, Germany Projektleder
Region Syddanmark
Læs mere om projektet
| |||
| Hospital@Night H@N | 2019 - 2022 | Grand Solutions
|
|
|
Hospital@Night H@N
Periode
2019 - 2022
Region
Region Midtjylland Program
Grand Solutions Fagområde
Biotek, Medico og Sundhed Investering
Percentage
67.51 Fondens investering
19,3 mio. Samlet budget
28,5 mio. Projektdeltagere
Aarhus University, Systematic A/S, Aalborg Universitetshospital, Aarhus University Hospital Projektleder
SYSTEMATIC A/S
Læs mere om projektet
| |||
| Virtual Clinical Trials VCT VCT | 2019 - 2021 | Grand Solutions
|
|
|
Virtual Clinical Trials VCT VCT
Periode
2019 - 2021
Region
Region Hovedstaden Program
Grand Solutions Fagområde
Biotek, Medico og Sundhed Investering
Percentage
48.53 Fondens investering
15,0 mio. Samlet budget
30,9 mio. Projektdeltagere
Leo Pharma A/S, Novo Nordisk A/S, Bispebjerg Hospital, Foreningen til fremme af kliniske forsøg i Danmark, Studies and Me Projektleder
LEO PHARMA A/S
Læs mere om projektet
| |||
| Precision Brain-Circuit Therapy (Precision-BCT): Personalized multi-target brain stimulation to restore brain function in treatment-resistant depression Precision-BCT | 2019 - 2024 | Grand Solutions
|
|
|
Precision Brain-Circuit Therapy (Precision-BCT): Personalized multi-target brain stimulation to restore brain function in treatment-resistant depression Precision-BCT
Periode
2019 - 2024
Region
Region Hovedstaden Program
Grand Solutions Fagområde
Biotek, Medico og Sundhed Investering
Percentage
63.86 Fondens investering
14,2 mio. Samlet budget
22,2 mio. Projektdeltagere
Hvidovre Hospital, Magventure A/S, Technical University of Denmark, Psykiatrisk Center Glostrup, University Hospital Munich, Ludwig-Maximilian University, Localite GmbH Projektleder
Region Hovedstaden
Læs mere om projektet
| |||
| Person-centric Health Innovation: New Service Models for Preventive Care Delivery to Elderly and Citizens with Chronical Conditions or at Risk of getting Chronical Conditions PreCare Phase II | 2019 - 2023 | Grand Solutions
|
|
|
Person-centric Health Innovation: New Service Models for Preventive Care Delivery to Elderly and Citizens with Chronical Conditions or at Risk of getting Chronical Conditions PreCare Phase II
Periode
2019 - 2023
Region
Region Sjælland Program
Grand Solutions Fagområde
Biotek, Medico og Sundhed Investering
Percentage
69.86 Fondens investering
20,0 mio. Samlet budget
28,6 mio. Projektdeltagere
Region Zealand, Odsherred kommune, Kommune 2, Kommune 3, Copenhagen Business School, Urgent Agency Projektleder
Region Sjælland
Læs mere om projektet
| |||
| IMPROVE Intervention Trial 2: Implementing non-invasive circulating tumor DNA analysis to optimize the operative and postoperative treatment for patients with colorectal cancer IMPROVE IT2 | 2019 - 2024 | Grand Solutions
|
|
|
IMPROVE Intervention Trial 2: Implementing non-invasive circulating tumor DNA analysis to optimize the operative and postoperative treatment for patients with colorectal cancer IMPROVE IT2
Periode
2019 - 2024
Region
Region Midtjylland Program
Grand Solutions Fagområde
Biotek, Medico og Sundhed Investering
Percentage
74.33 Fondens investering
12,6 mio. Samlet budget
16,9 mio. Projektdeltagere
Aarhus University Hospital, Regionshospitalet Randers, Genodesk Aps, Aarhus University Hospital, University of Southern Denmark Projektleder
Region Midtjylland
Læs mere om projektet
| |||
| Adherence through cloud-based Personalised Treatment for Type 2 Diabetes ADAPT-T2D ADAPT-T2D | 2019 - 2024 | Grand Solutions
|
|
|
Adherence through cloud-based Personalised Treatment for Type 2 Diabetes ADAPT-T2D ADAPT-T2D
Periode
2019 - 2024
Region
Region Hovedstaden Program
Grand Solutions Fagområde
Biotek, Medico og Sundhed Investering
Percentage
52.12 Fondens investering
17,1 mio. Samlet budget
32,9 mio. Projektdeltagere
Novo Nordisk A/S, Aalborg Universitetshospital, Region Sjælland, Aalborg University, Technical University of Denmark, University of Cambridge, Glooko AB Projektleder
NOVO NORDISK A/S
Læs mere om projektet
| |||